BCM
EW icon

Becker Capital Management’s Edwards Lifesciences EW Stock Holding History

Becker Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,764
Closed -$2.43M – 268
2023
Q2 		$2.43M Buy
25,764
+2,140
+9% +$186K 0.09% 118
2023
Q1 		$1.95M Buy
23,624
+3,334
+16% +$262K 0.08% 130
2022
Q4 		$1.51M Buy
20,290
+11,929
+143% +$919K 0.07% 108
2022
Q3 		$691K Buy
8,361
+763
+10% +$73.4K 0.04% 137
2022
Q2 		$722K Buy
+7,598
New +$787K 0.03% 137

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Becker Capital Management's EW Position: Q3 2023 in Review

Becker Capital Management sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 25,764 shares — an estimated $2.43M sold.

Becker Capital Management first reported a position in EW in Q2 2022 and held it in 5 quarters. The position peaked at $2.43M in Q2 2023. 1,219 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Becker Capital Management reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
  • Becker Capital Management sold 25,764 Edwards Lifesciences shares in Q3 2023, an estimated $2.43M.
  • Becker Capital Management first reported a position in Edwards Lifesciences in Q2 2022 and held it in 5 quarters.
  • Becker Capital Management's Edwards Lifesciences position peaked at $2.43M in Q2 2023.
  • 1,219 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Becker Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.